Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Shores Medical Group is a California-based community oncology and hematology medical practice that provides diagnosis, treatment, and supportive care for patients with cancer and blood disorders. The organization appears to operate as a physician group practice rather than a drug-development biotech or pharmaceutical company. Its services include hematology/oncology care and outpatient intravenous infusion services, with operations centered in Long Beach and additional Southern California locations. Publicly available sources indicate the entity is an active private medical group founded in the early 1990s and led by N. Simon Tchekmedyian, M.D. For biotech-style pipeline analysis, the company does not appear to disclose proprietary therapeutics or an R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Shores Medical Group.